Notice: This company has been marked as potentially delisted and may not be actively trading. DermTech (DMTK) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends DermTech Short Interest DataDermTech (DMTK) has a short interest of 3.02 million shares, representing 9.50% of the float (the number of shares available for trading by the public). This marks a -10.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 1.07 million shares to cover all short positions.Current Short Interest3,020,000 sharesPrevious Short Interest3,360,000 sharesChange Vs. Previous Month-10.12%Dollar Volume Sold Short$962,776.00Short Interest Ratio1.8 Days to CoverLast Record DateJune 15, 2024Outstanding Shares34,963,000 sharesFloat Size31,790,000 sharesShort Percent of Float9.50%Today's Trading Volume3,662,300 sharesAverage Trading Volume1,065,175 sharesToday's Volume Vs. Average344% Short Selling DermTech? Sign up to receive the latest short interest report for DermTech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDMTK Short Interest Over TimeDMTK Days to Cover Over TimeDMTK Percentage of Float Shorted Over Time Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! DermTech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20243,020,000 shares $962,776.00 -10.1%9.5%1.8 $0.32 5/31/20243,360,000 shares $1.06 million +17.9%10.5%6.4 $0.32 5/15/20242,850,000 shares $1.62 million -7.8%8.9%4.8 $0.57 4/30/20243,090,000 shares $1.92 million +0.3%10.1%10.9 $0.62 4/15/20243,080,000 shares $1.91 million -2.5%10.1%10.5 $0.62 3/31/20243,160,000 shares $2.22 million +0.6%10.3%9.4 $0.70 Get the Latest News and Ratings for DMTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DermTech and its competitors with MarketBeat's FREE daily newsletter. 3/15/20243,140,000 shares $2.17 million -0.3%10.3%7.7 $0.69 2/29/20243,150,000 shares $4.03 million -5.1%10.3%6.2 $1.28 2/15/20243,320,000 shares $4.45 million +0.3%11.0%8 $1.34 1/31/20243,310,000 shares $3.97 million +4.1%10.9%7.8 $1.20 1/15/20243,180,000 shares $4.52 million +4.3%10.5%7.3 $1.42 12/31/20233,050,000 shares $5.34 million +2.0%10.1%7 $1.75 12/15/20232,990,000 shares $4.63 million -47.6%9.9%7.4 $1.55 11/30/20235,710,000 shares $9.19 million +6.3%18.9%17.1 $1.61 11/15/20235,370,000 shares $8.32 million +4.1%17.8%22 $1.55 10/31/20235,160,000 shares $7.02 million -1.3%17.1%21.1 $1.36 10/15/20235,230,000 shares $6.38 million +7.2%17.6%21 $1.22 9/30/20234,880,000 shares $7.03 million +3.4%16.4%18.8 $1.44 9/15/20234,720,000 shares $8.54 million -2.1%15.8%17.1 $1.81 8/31/20234,820,000 shares $11.09 million +10.1%16.3%14.9 $2.30 8/15/20234,380,000 shares $10.47 million +7.6%14.9%13.1 $2.39 7/31/20234,070,000 shares $13.19 million +4.9%13.8%10.9 $3.24 7/15/20233,880,000 shares $12.26 million +6.6%14.3%9.1 $3.16 6/30/20233,640,000 shares $9.46 million +12.7%13.4%8.7 $2.60 6/15/20233,230,000 shares $9.37 million +14.5%11.9%8.1 $2.90 5/31/20232,820,000 shares $6.71 million -3.1%9.8%7.6 $2.38 5/15/20232,910,000 shares $6.87 million No Change10.1%7 $2.36 10/31/20222,770,000 shares $8.92 million -2.5%10.5%5.2 $3.22 10/15/20222,840,000 shares $9.57 million -3.4%10.8%5.4 $3.37 9/30/20222,940,000 shares $11.64 million +1.7%11.2%5 $3.96 9/15/20222,890,000 shares $16.01 million +2.9%11.0%4.5 $5.54 8/31/20222,810,000 shares $15.62 million -0.7%10.7%3.5 $5.56 8/15/20222,830,000 shares $20.26 million -29.3%10.8%3.2 $7.16 7/31/20224,000,000 shares $32.80 million +29.0%15.3%4.3 $8.20 7/15/20223,100,000 shares $19.56 million -8.0%11.9%3.2 $6.31 6/30/20223,370,000 shares $18.67 million -36.2%12.9%3.7 $5.54 6/15/20225,280,000 shares $25.03 million +2.3%20.1%5.7 $4.74 5/31/20225,160,000 shares $34.26 million -1.2%19.7%6.6 $6.64 5/15/20225,220,000 shares $40.92 million -19.8%19.8%7 $7.84 4/30/20226,510,000 shares $55.66 million +11.3%24.7%9.6 $8.55Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. 4/15/20225,850,000 shares $69.91 million +5.2%22.3%9 $11.95 3/31/20225,560,000 shares $81.62 million -0.9%N/A8.1 $14.68 3/15/20225,610,000 shares $65.86 million -2.3%21.0%7.9 $11.74 2/28/20225,740,000 shares $73.41 million -2.4%21.6%7.7 $12.79 2/15/20225,880,000 shares $81.44 million +3.9%22.1%7.9 $13.85 1/31/20225,660,000 shares $72.50 million +9.9%21.3%7.2 $12.81 1/15/20225,150,000 shares $74.57 million +3.4%19.4%6.9 $14.48 12/31/20214,980,000 shares $78.68 million +4.6%18.8%7.4 $15.80 12/15/20214,760,000 shares $81.73 million -0.2%18.0%8.1 $17.17 11/30/20214,770,000 shares $95.78 million +8.7%18.0%9.8 $20.08 11/15/20214,390,000 shares $104.96 million -4.4%16.6%9.8 $23.91 10/29/20214,590,000 shares $125.54 million +0.4%17.4%11.7 $27.35 10/15/20214,570,000 shares $142.95 million +3.6%18.6%11.1 $31.28 9/30/20214,410,000 shares $141.61 million +6.5%17.9%9.6 $32.11 9/15/20214,140,000 shares $143.04 million -3.5%16.8%7 $34.55 8/31/20214,290,000 shares $159.59 million -4.5%17.5%6.6 $37.20 8/13/20214,490,000 shares $153.60 million -3.9%18.4%6.1 $34.21 7/30/20214,670,000 shares $157.19 million -8.3%19.6%5.5 $33.66 7/15/20215,090,000 shares $172.50 million -4.5%21.3%5.2 $33.89 6/30/20215,330,000 shares $221.57 million +8.1%22.3%4.8 $41.57 6/15/20214,930,000 shares $203.21 million -5.7%20.6%4.5 $41.22 5/28/20215,230,000 shares $214.01 million -2.6%21.9%4.2 $40.92 5/14/20215,370,000 shares $156.48 million +5.5%N/A3.8 $29.14 4/30/20215,090,000 shares $214.14 million +6.3%N/A3.2 $42.07 4/15/20214,790,000 shares $211.29 million +2.8%N/A3.1 $44.11 3/31/20214,660,000 shares $219.07 million +84.9%N/A3 $47.01 3/15/20212,520,000 shares $134.95 million +62.6%N/A1.6 $53.55 2/26/20211,550,000 shares $110.30 million +73.7%N/A1.1 $71.16 2/12/2021892,300 shares $59.56 million -50.7%N/A0.8 $66.75 1/29/20211,810,000 shares $77.87 million +16.8%N/A2.1 $43.02 1/15/20211,550,000 shares $61.49 million +33.6%N/A2.2 $39.67 12/31/20201,160,000 shares $41.40 million +21.5%N/A2.3 $35.69 12/15/2020954,700 shares $13.32 million +45.2%N/A3.7 $13.95 11/30/2020657,700 shares $8.34 million +118.7%N/A5 $12.68 11/15/2020300,800 shares $4.03 million +19.5%N/A2.4 $13.41 10/30/2020251,700 shares $2.96 million -3.3%N/A2.3 $11.75 10/15/2020260,200 shares $3.00 million -18.9%N/A2.2 $11.53 9/30/2020321,000 shares $3.84 million +7.1%N/A2.7 $11.95 9/15/2020299,700 shares $3.41 million +34.0%N/A2.1 $11.39 8/31/2020223,600 shares $2.63 million -11.9%N/A1.6 $11.77 8/14/2020253,900 shares $3.12 million -24.7%N/A1.9 $12.30 7/31/2020337,100 shares $3.57 million -1.9%N/A2.7 $10.59 7/15/2020343,700 shares $3.92 million -1.6%N/A3.2 $11.41 6/30/2020349,100 shares $4.76 million +133.5%N/A3.6 $13.64 6/15/2020149,500 shares $1.98 million -34.3%N/A2.2 $13.23 5/29/2020227,700 shares $2.59 million +24.8%N/A4.1 $11.37 5/15/2020182,500 shares $2.28 million -6.3%N/A3.6 $12.50 4/30/2020194,700 shares $2.68 million -6.9%N/A4.1 $13.75 4/15/2020209,100 shares $2.47 million -2.9%N/A4.6 $11.81 3/31/2020215,300 shares $2.67 million +113.0%N/A4 $12.42Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. 3/13/2020101,100 shares $1.19 million +33.4%N/A1.2 $11.76 2/28/202075,800 shares $680,684.00 -0.7%N/A1.2 $8.98 2/14/202076,300 shares $1.17 million -10.7%N/A1.3 $15.30 1/31/202085,400 shares $1.05 million +1.2%1.6%1.5 $12.27 1/15/202084,400 shares $1.10 million -30.0%1.6%1.4 $13.00 12/31/2019120,600 shares $1.60 million +58.7%2.3%2 $13.25 DMTK Short Interest - Frequently Asked Questions What is DermTech's current short interest? Short interest is the volume of DermTech shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 3,020,000 shares of DMTK short. 9.50% of DermTech's shares are currently sold short. Learn More on DermTech's current short interest. What is a good short interest ratio for DermTech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMTK shares currently have a short interest ratio of 2.0. Learn More on DermTech's short interest ratio. What is a good short interest percentage for DermTech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.50% of DermTech's floating shares are currently sold short. Is DermTech's short interest increasing or decreasing? DermTech saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 3,020,000 shares, a decrease of 10.1% from the previous total of 3,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is DermTech's float size? DermTech currently has issued a total of 34,963,000 shares. Some of DermTech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. DermTech currently has a public float of 31,790,000 shares. How does DermTech's short interest compare to its competitors? 9.50% of DermTech's shares are currently sold short. Here is how the short interest of companies compare to DermTech: Centogene (0.69%), The Oncology Institute, Inc. (0.67%), BioRestorative Therapies, Inc. (0.87%), Ontrak, Inc. (3.75%), ATI Physical Therapy, Inc. (0.86%), Mangoceuticals, Inc. (15.31%), Agape ATP Co. (7.86%), Kindly MD, Inc. (17.08%), BioNexus Gene Lab Corp. (1.20%), Vsee Health, Inc. (1.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short DermTech stock? Short selling DMTK is an investing strategy that aims to generate trading profit from DermTech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DermTech? A short squeeze for DermTech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMTK, which in turn drives the price of the stock up even further. How often is DermTech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMTK, twice per month. The most recent reporting period available is June, 15 2024. More Short Interest Resources from MarketBeat Related Companies CNTG Short Squeeze TOI Short Squeeze BRTX Short Squeeze OTRK Short Squeeze ATIP Short Squeeze MGRX Short Squeeze ATPC Short Squeeze KDLY Short Squeeze BGLC Short Squeeze VSEE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DMTK) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DermTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DermTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
